Product Images Ketorolac Tromethamine

This text appears to be a table of pharmacokinetic parameters for a medication. It includes information about the bioavailability, absorption rate, peak plasma concentration, and volume of distribution for different dosages of the medication when administered orally, intramuscularly, or intravenously. The table also includes information on the steady-state plasma concentrations and the percentage of the dose metabolized or excreted in urine or feces. However, some of the text is not readable due to errors, so not all of the information is available.*

This table shows the impact of age, liver and kidney function on Ketorolac Tromethamine clearance and terminal half-life in adult populations. The table includes information on total clearance in liters per kilogram and terminal half-life in hours for different types of subjects such as normal subjects, healthy elderly subjects, Patients with hepatic, renal impairment and renal dialysis patients. The data is estimated from a single dose of 30mg Ketorolac Tromethamine administered intramuscularly and 10mg administered orally.*

This text appears to be a list of possible experiences or side effects related to gastrointestinal issues and other conditions or treatments. These include abdominal pain, constipation, diarrhea, dyspepsia, flatulence, fullness, ulcers, bleeding, heartburn, nausea, stomatitis, vomiting, abnormal renal function, anemia, dizziness, drowsiness, edema, elevated liver enzymes, headaches, hypertension, increased bleeding time, injection site pain, pruritus, purpura, rashes, tinnitus, and sweating. Some of these experiences have an incidence greater than 10%.*

This is a table displaying the rates of total daily doses of Ketorolac Tromethamine Injection given to adult patients with and without a history of PUB (possibly standing for "Peptic Ulcer Bleed"), categorized based on the age of patients and the dosage level. The table shows the percentage of patients in each group who received doses less than 60mg or more than 60, 90, and 120mg.*

This is a description of Ketorolac Tromethamine Injection which contains its NDC numbers, package factor and the number of vials provided in a carton. The injection is available in different strengths, with the 15mg/mL, 30mg/mL, and 60mg/2 mL variants provided as 1mL single-dose vials while the 60mg/2mL variant is provided in 2mL single-dose vials. It is only recommended for intramuscular use.*

Ketorolac Tromethamine is a medication that is available in a 60mg/2mL single-dose vial for injection use only. It should be protected from light and discarded if unused. The medication is intended for use by prescription only and should be kept out of reach of children. The product should be stored at a controlled temperature between 66°F and 77°F. The packaging includes information on the manufacturer, lot number, expiration date, and prescribing information. Available from manufacturer Miraject Inc.*